Bayer

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Pharma

Bayer's Nubeqa eyes wider market after phase 3 win

Nubeqa significantly improved metastasis-free survival when added to standard-of-care treatment in very high-risk localized prostate cancer.
Donavyn Coffey Oct 24, 2026 8:30am
Bayer cross

Melissa explains it all in menopause team up with Bayer

Oct 8, 2026 9:24am
Bayer Bayer Ohio New Albany

Bayer doubles down on US with $2.2B Ohio manufacturing project

Oct 2, 2026 3:10pm
Stivarga

Bayer sells cancer drug Stivarga to Grünenthal for up to $431M

Sep 21, 2026 10:20am
FDA approved stamp regulations yes go

Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes

Sep 17, 2026 2:06pm
Bayer cross

FDA christens Hyrnuo a first-line option for rare lung cancer

Sep 9, 2026 4:33pm